187 related articles for article (PubMed ID: 29126666)
1. Preparation and immunological evaluation of inactivated avian influenza virus vaccine encapsulated in chitosan nanoparticles.
Mohamed SH; Arafa AS; Mady WH; Fahmy HA; Omer LM; Morsi RE
Biologicals; 2018 Jan; 51():46-53. PubMed ID: 29126666
[TBL] [Abstract][Full Text] [Related]
2. Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus.
Lone NA; Spackman E; Kapczynski D
Vaccine; 2017 Jun; 35(26):3401-3408. PubMed ID: 28511853
[TBL] [Abstract][Full Text] [Related]
3. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
Singh SM; Alkie TN; Nagy É; Kulkarni RR; Hodgins DC; Sharif S
Vaccine; 2016 Sep; 34(40):4807-13. PubMed ID: 27543454
[TBL] [Abstract][Full Text] [Related]
4. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia.
Isoda N; Sakoda Y; Kishida N; Soda K; Sakabe S; Sakamoto R; Imamura T; Sakaguchi M; Sasaki T; Kokumai N; Ohgitani T; Saijo K; Sawata A; Hagiwara J; Lin Z; Kida H
Arch Virol; 2008; 153(9):1685-92. PubMed ID: 18651092
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics.
Tian G; Zhang S; Li Y; Bu Z; Liu P; Zhou J; Li C; Shi J; Yu K; Chen H
Virology; 2005 Oct; 341(1):153-62. PubMed ID: 16084554
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
Singh SM; Alkie TN; Abdelaziz KT; Hodgins DC; Novy A; Nagy É; Sharif S
Viral Immunol; 2016 Jun; 29(5):269-75. PubMed ID: 27077969
[TBL] [Abstract][Full Text] [Related]
7. In ovo vaccination of chicken embryos with experimental Newcastle disease and avian influenza oil-emulsion vaccines.
Stone H; Mitchell B; Brugh M
Avian Dis; 1997; 41(4):856-63. PubMed ID: 9454919
[TBL] [Abstract][Full Text] [Related]
8. Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens.
Alkie TN; Yitbarek A; Taha-Abdelaziz K; Astill J; Sharif S
PLoS One; 2018; 13(11):e0206324. PubMed ID: 30383798
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge.
Steensels M; Van Borm S; Lambrecht B; De Vriese J; Le Gros FX; Bublot M; van den Berg T
Avian Dis; 2007 Mar; 51(1 Suppl):325-31. PubMed ID: 17494576
[TBL] [Abstract][Full Text] [Related]
10. Detection of antibodies to the nonstructural protein (NS1) of avian influenza viruses allows distinction between vaccinated and infected chickens.
Zhao S; Jin M; Li H; Tan Y; Wang G; Zhang R; Chen H
Avian Dis; 2005 Dec; 49(4):488-93. PubMed ID: 16404988
[TBL] [Abstract][Full Text] [Related]
11. Avian influenza virus vaccines containing Toll-like receptors 2 and 5 ligand adjuvants promote protective immune responses in chickens.
St Paul M; Brisbin JT; Barjesteh N; Villaneueva AI; Parvizi P; Read LR; Nagy E; Sharif S
Viral Immunol; 2014 May; 27(4):160-6. PubMed ID: 24797722
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
Zhao J; Yang H; Xu H; Ma Z; Zhang G
Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Infectious Bursal Disease Virus-Induced Immunosuppression on Vaccination Against Highly Pathogenic Avian Influenza Virus.
Spackman E; Stephens CB; Pantin-Jackwood MJ
Avian Dis; 2018 Mar; 62(1):36-44. PubMed ID: 29620467
[TBL] [Abstract][Full Text] [Related]
14. Coadministration of Recombinant Adenovirus Expressing GM-CSF with Inactivated H5N1 Avian Influenza Vaccine Increased the Immune Responses and Protective Efficacy Against a Wild Bird Source of H5N1 Challenge.
Wang X; Wang X; Jia Y; Wang C; Tang Q; Han Q; Xiao S; Yang Z
J Interferon Cytokine Res; 2017 Oct; 37(10):467-473. PubMed ID: 29028432
[TBL] [Abstract][Full Text] [Related]
15. Positive regulation of humoral and innate immune responses induced by inactivated Avian Influenza Virus vaccine in broiler chickens.
Abdallah F; Hassanin O
Vet Res Commun; 2015 Dec; 39(4):211-6. PubMed ID: 26329833
[TBL] [Abstract][Full Text] [Related]
16. A Dose-Response Study of Inactivated Low Pathogenic Avian Influenza H9N2 Virus in Specific-Pathogen-Free and Commercial Broiler Chickens.
Kilany WH; Ali A; Bazid AH; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
Avian Dis; 2016 May; 60(1 Suppl):256-61. PubMed ID: 27309065
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens.
Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S
Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508
[TBL] [Abstract][Full Text] [Related]
18. Induction of respiratory immune responses in the chicken; implications for development of mucosal avian influenza virus vaccines.
de Geus ED; Rebel JM; Vervelde L
Vet Q; 2012 Jun; 32(2):75-86. PubMed ID: 22862156
[TBL] [Abstract][Full Text] [Related]
19. Effects of ligands for Toll-like receptors 3, 4, and 21 as adjuvants on the immunogenicity of an avian influenza vaccine in chickens.
St Paul M; Barjesteh N; Brisbin JT; Villaneueva AI; Read LR; Hodgins D; Nagy É; Sharif S
Viral Immunol; 2014 May; 27(4):167-73. PubMed ID: 24797893
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of an inactivated vaccine against H9N2 avian influenza virus in ducks.
Teng Q; Shen W; Liu Q; Rong G; Chen L; Li X; Chen H; Yang J; Li Z
Virol J; 2015 Sep; 12():143. PubMed ID: 26377565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
